Figure S21 from SETD2 Deficiency Drives Mitochondrial DNA Leakage and Creates a Druggable Dependency on BCL-xL in Clear Cell Renal Cell Carcinoma

Authors: Anusha Uprety, Chandler Judd, Emily D. Villella et al.

Publication:

Published: Unknown date

Source: Crossref

Back to Search View Original Cite This Article

Abstract

<jats:p><p>Figure S21. Time-course analysis of A-1331852 treatment in SETD2 WT and SETD2-deficient 786-O cells. Cells were treated with DMSO or 100nM A-1331852 and harvested at 24, 48, and 72 hours. Inflammatory signaling pathway activation was evaluated by immunoblot analysis of indicated proteins. KU80 was used as a loading control.</p></jats:p>

Keywords

analysis a1331852 cells pfigure timecourse

Figure S21 from SETD2 Deficiency Drives Mitochondrial DNA Leakage and Creates a Druggable Dependency on BCL-xL in Clear Cell Renal Cell Carcinoma

Abstract

Keywords

Related Articles

Supplementary Table S8 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer

Supplementary Figure S9 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer

Figure S8 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer

Table S11 from GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma

Table S1 from GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma